Loading...

Cell Activation Cocktail (without Brefeldin A)

Pricing & Availability
Regulatory Status
RUO
Other Names
Cell Stimulation Cocktail, PMA/Ionomycin
Ave. Rating
Submit a Review
Product Citations
publications
Cell_Activation_Cocktail_without_Brefeldin_1_012815
Human peripheral blood lymphocytes were stimulated with Cell Activation cocktail without Brefeldin A for six hours, then surface stained with CD3 APC and CD154 (clone 24-31) Brilliant Violet 421™ (top) or CD25 (clone BC96) PE (bottom).
  • Cell_Activation_Cocktail_without_Brefeldin_1_012815
    Human peripheral blood lymphocytes were stimulated with Cell Activation cocktail without Brefeldin A for six hours, then surface stained with CD3 APC and CD154 (clone 24-31) Brilliant Violet 421™ (top) or CD25 (clone BC96) PE (bottom).
  • Cell_Activation_Cocktail_without_Brefeldin_2_012815
Cat # Size Price Quantity Check Availability Save
423301 100 µL 89 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423302 400 µL 265 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Cell Activation Cocktail (without Brefeldin A) is a pre-mixed cocktail with optimized concentration of PMA (phorbol 12-myristate-13-acetate) and ionomycin. Activation of cells by PMA and ionomycin leads to an increase in cell surface expression of certain markers such as CD69 and CD154, which can be detected using this cocktail.

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Cell Activation Cocktail (without Brefeldin A) is composed of PMA and ionomycin.
Concentration
Each vial of this cocktail contains phorbol-12-myristate 13-acetate 40.5 µM (25 ug/mL) and ionomycin 669.3 µM (500 ug/mL) in DMSO (500X).
Storage & Handling
Store cocktail at -70°C upon receipt. Protect from light. Avoid repeat freeze/thaw cycles.
Application

Activ, FC, ICFC - Quality tested
Recommended Usage

Cat. No. 423301 contains 100 µL of cocktail, formulated at 500X, that can be used for activating 50 mL of cells of various types.

Cat. No. 423302 contains 400 µL (4 vials x 100 µL per vial) of cocktail, formulated at 500X, that can be used for activating 200 mL of cells of various types.

Application Notes

Cell Activation Protocol:
1. Resuspend cells of interest in desired cell culture medium. Recommended cell suspension is between 1-2 x 106 cells/mL, although effective activation can be obtained with higher or lower concentration.
2. Completely thaw vials in 37°C water bath.
3. Add 2 µL of the cocktail to each mL of cell suspension.
4. Incubate cells at 37°C in a CO2 incubator for 6 hours or the time period of interest.
5. Harvest activated cells and centrifuge at 350g for 5 minutes. Discard supernatant.
6. Add 2.5 mL of Cell Staining Buffer (Cat. No. 420201) to the cell pellet, mix by vortex or pipetting, then centrifuge at 350g for 5 minutes. Discard supernatant.
7. Repeat step 6.
8. Cells are now ready to be tested for surface markers or proteins of interest.

Note: If investigators are interested in detecting intracellular proteins following activation, this product can be used in conjunction with Monensin (Cat. No. 420701) or Brefeldin A (Cat. No. 420601).

This product is temperature sensitive; repeated freeze/thaw is not recommended.

Intracellular and surface flow staining, as well as ELISA, can be performed following activation of cells with this cocktail.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Product Citations
  1. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  2. Matiza T, et al. 2021. Medicine (Baltimore). 100:e28328. PubMed
  3. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  4. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  5. Tran TA, et al. 2023. Front Immunol. 13:1009484. PubMed
  6. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  7. Freimer JW, et al. 2022. Nat Genet. 54:1133. PubMed
  8. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  9. Zhou Y, et al. 2023. Front Immunol. 14:1129705. PubMed
  10. Hu Y, et al. 2023. Front Immunol. 14:1128423. PubMed
  11. Gary EN, et al. 2023. Front Immunol. 14:1138609. PubMed
  12. Jung HS, et al. 2023. iScience. 26:106621. PubMed
  13. Malamba-Banda C, et al. 2023. Sci Rep. 13:9001. PubMed
  14. McLean BA, et al. 2021. JCI Insight. 6:. PubMed
  15. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  16. Carpenter RS, et al. 2019. Sci Rep. 9:19105. PubMed
  17. Ayenehdeh J, et al. 2017. Immunology Letters. 10.1016/j.imlet.2017.05.006. PubMed
  18. Vazquez J, et al. 2020. Front Immunol. 2.545138889. PubMed
  19. Nagle VL, et al. 2022. Mol Cancer Ther. 21:658. PubMed
  20. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  21. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  22. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  23. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  24. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  25. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  26. Lee J, et al. 2020. Sci Rep. 10:17753. PubMed
  27. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  28. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  29. Owyong M, et al. 2019. Life Sci Alliance. 2:e201800226. PubMed
  30. Kumar RK, et al. 2021. Vascul Pharmacol. 138:106838. PubMed
  31. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  32. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  33. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  34. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  35. Einkauf KB, et al. 2022. Cell. 185:266. PubMed
  36. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  37. Michoud F, et al. 2020. Nat Biotechnol. . PubMed
  38. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  39. Trial J, et al. 2020. Geroscience. . PubMed
  40. Spencer AJ, et al. 2022. EBioMedicine. 77:103902. PubMed
  41. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  42. Mysore V, et al. 2021. Med (N Y). 2:1050. PubMed

Antigen Details

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 4    Revision Date: 07.06.2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account